glp 1 during perimenopause 10 Things No One Tells You About GLP-1s in GLP-1 Weight Loss in Menopause:

This drug activates GLP-1 receptors for blood sugar control

Introducing an exogenous GH secretagogue into this already highly activated system is physiologically distinct from introducing it into a 35-year-old with age-related GH decline

This barrier severely restricts drug delivery and prevents potentially effective central nervous system treatments from being used clinically [112]

PR: Data curation, Writing original draft

Lancet 397(10278):971984 Shi I, Khan SS, Yeh RW, Ho JE, Dahabreh IJ, Kazi DS (2025) Semaglutide Eligibility Across All Current Indications for US Adults

Additionally, these nutrients help to maintain low levels of homocysteine, a potentially toxic chemical that can lead to stroke and atherosclerosis